循环小细胞外囊泡介导糖尿病中的血管高通透性
研究探讨2型糖尿病中循环小细胞外囊泡(sEVs)是否通过表型变化破坏血管屏障。糖尿病小鼠和糖尿病患者的sEVs数量增多、体积增大,可经MEK/ROCK通路快速持久破坏内皮细胞屏障,但不引起炎症;蛋白酶K处理或MEK/ROCK抑制剂可减少该效应。
要点
- 糖尿病小鼠和糖尿病患者循环sEVs数量增多、体积增大。
- 糖尿病来源sEVs经MEK/ROCK通路破坏内皮屏障,不诱导炎症。
- 蛋白酶K处理或MEK/ROCK抑制剂可减少sEVs致高通透性效应。
核心结论
- 糖尿病与循环sEVs浓度和体积显著增加相关,sEVs相关蛋白调控可经MEK/ROCK通路激活诱导血管渗漏,可能参与2型糖尿病认知下降的发病机制。
研究设计与样本
- 从2型糖尿病小鼠模型和糖尿病患者血浆中分离sEVs,表征其破坏内皮细胞屏障的能力,并用蛋白质组学和小分子抑制剂进行功能探究。
主要发现
- 糖尿病小鼠(Leprdb/db)脑微血管呈现高通透性,静脉注射糖尿病小鼠sEVs可在非糖尿病受体小鼠中重现血管渗漏增强。
- 糖尿病小鼠和人类血浆循环sEVs数量与体积较非糖尿病对照增加,糖尿病来源sEVs快速持久破坏内皮细胞屏障,增强旁细胞和跨细胞渗漏但不诱导炎症。
- sEVs蛋白质组和受体内皮细胞磷酸化蛋白质组分析提示糖尿病来源sEVs调控MAPK/MEK和ROCK通路、细胞间连接和肌动蛋白动力学,并经实验证实。
- 蛋白酶K处理sEVs或MEK/ROCK抑制剂预处理受体细胞可减少糖尿病状态下循环sEVs诱导的高通透性效应。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: A hallmark chronic complication of type 2 diabetes mellitus is vascular hyperpermeability, which encompasses dysfunction of the cerebrovascular endothelium and the subsequent development of associated cognitive impairment. The present study tested the hypothesis that during type 2 diabetes circulating small extracellular vesicles (sEVs) exhibit phenotypic changes that facilitate pathogenic disruption of the vascular barrier. METHODS: sEVs isolated from the plasma of a mouse model of type 2 diabetes and from diabetic human individuals were characterised for their ability to disrupt the endothelial cell (EC) barrier. The contents of sEVs and their effect on recipient ECs were assessed by proteomics and identified pathways were functionally interrogated with small molecule inhibitors. RESULTS: Using intravital imaging, we found that diabetic mice (Leprdb/db) displayed hyperpermeability of the cerebrovasculature. Enhanced vascular leakiness was recapitulated following i.v. injection of sEVs from diabetic mice into non-diabetic recipient mice. Characterisation of circulating sEV populations from the plasma of diabetic mice and humans demonstrated increased quantity and size of sEVs compared with those isolated from non-diabetic counterparts. Functional experiments revealed that sEVs from diabetic mice or humans induced the rapid and sustained disruption of the EC barrier through enhanced paracellular and transcellular leak but did not induce inflammation. Subsequent sEV proteome and recipient EC phospho-proteome analysis suggested that extracellular vesicles (sEVs) from diabetic mice and humans modulate the MAPK/MAPK kinase (MEK) and Rho-associated protein kinase (ROCK) pathways, cell-cell junctions and actin dynamics. This was confirmed experimentally. Treatment of sEVs with proteinase K or pre-treatment of recipient cells with MEK or ROCK inhibitors reduced the hyperpermeability-inducing effects of circulating sEVs in the diabetic state. CONCLUSIONS/INTERPRETATION: Diabetes is associated with marked increases in the concentration and size of circulating sEVs. The modulation of sEV-associated proteins under diabetic conditions can induce vascular leak through activation of the MEK/ROCK pathway. These data identify a new paradigm by which diabetes can induce hyperpermeability and dysfunction of the cerebrovasculature and may implicate sEVs in the pathogenesis of cognitive decline during type 2 diabetes.
引用
- Gustafson D, DiStefano PV, Wang XF, et al. Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes. Diabetologia. 2024. PMID: 38489029. doi:10.1007/s00125-024-06120-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。